MedElevator Войти в исследования
← Поиск публикаций
Медицинская библиотека · Anticancer research · 2009

Clinical outcomes of unrelated donor umbilical cord blood transplantation for 30 adults with hematological malignancies.

Kobayashi Koichiro, Maeda Yoshinobu, Hara Yoshitaka, Nishie-Kataoka Miyuki, Nishimori Hisakazu, Sugiyama Haruko, Namba Noriko, Kubonishi Shiro, Niiya Masami, Shinagawa Katsuji, Ikeda Kazuma, Tanimoto Mitsune

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Umbilical cord blood transplantation (CBT) has increasingly been used as a therapeutic option for adult patients for whom allogeneic stem-cell transplantation is not indicated, due to the availability of cord blood. However, myeloablative conditioning regimens are associated with significant mortality, and high relapse rates in reduced-intensity regimens may result in a poor rate of disease-free survival for those with advanced stages of hematological malignancies. Therefore, it remains unknown whether CBT is a truly effective option for such adults with high-risk disease, as well as for those with standard-risk disease.

PATIENTS AND

METHODS

Thirty adult patients with a median age of 45 years (range: 16-67) with standard or high-risk disease underwent CBT from unrelated donors at Okayama University Hospital between October 2002 and May 2007. Twenty-one patients had diseases classified as high-risk for transplantation. The median number of nucleated cells in infused cord blood was 2.65 x 10(7)/kg (range: 1.73-4.87).

RESULTS

Twenty-three patients achieved neutrophil engraftment at a median time of 22 days (range: 13-42) after CBT. The cumulative incidence of grade II to IV acute graft-versus-host disease (GVHD) was 53.6% . Out of the 30 patients, 11 were alive and disease-free at a median time of 446 days (range: 124-1153) after CBT. The cumulative 1-year overall survival in patients with standard-risk or high-risk disease was 63.5% and 15.4%, respectively (p=0.01).

CONCLUSION

Although from a retrospective study, these results suggest that unrelated donor CBT could be safe and effective for adult patients with standard-risk disease who cannot find a suitable HLA-matched volunteer marrow or peripheral blood donor.

Для цитирования: Kobayashi Koichiro, Maeda Yoshinobu, Hara Yoshitaka, Nishie-Kataoka Miyuki, Nishimori Hisakazu, Sugiyama Haruko, Namba Noriko, Kubonishi Shiro, Niiya Masami, Shinagawa Katsuji, Ikeda Kazuma, Tanimoto Mitsune. Clinical outcomes of unrelated donor umbilical cord blood transplantation for 30 adults with hematological malignancies.. Anticancer research. 2009.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.